Skip to Main Content

Awareness weeks

Health Awareness Week

 

World Glaucoma Week

March 12-18, 2023

World Glaucoma Week is a global initiative of the World Glaucoma Association (WGA) in order to raise awareness on glaucoma. Through a series of engaging worldwide activities, patients, eye-care providers, health officials and the general public are invited to contribute to sight preservation. The goal is to alert everyone to have regular eye (and optic nerve) checks in order to detect glaucoma as early as possible. World Glaucoma Week

UpToDate

Articles

Diagnosis

Research

Treatment

Journals

E-books

_________________________________________________________________________________

Articles

Diagnosis

Quality of life in children with glaucoma: a qualitative interview study in Australia
The psychosocial impact of childhood glaucoma extends beyond the clinical environment and was minimised using coping strategies. Older children may require additional social and ophthalmic support as they transition into adulthood. Ophthalmology 20 July 2022

Application of diffusion tensor imaging technology in glaucoma diagnosis
In order to provide a more solid foundation for the degenerative characteristics of glaucoma, this paper will discuss the standard diagnostic techniques for glaucoma through a review of the literature, describe the use of DTI technology in glaucoma in humans and animal models, and introduce these techniques. With the advancement of DTI technology and its coupling with artificial intelligence, DTI represents a potential future for MRI technology in glaucoma research. Frontiers in neuroscience 2 February 2023

Glaucoma in adults-diagnosis, management, and pre-diagnosis to end-stage, categorizing Glaucoma's stages: A review
By identifying systemic illnesses and drugs that raise a patient's chance of developing glaucoma and referring high-risk individuals for a thorough ophthalmologic examination, vision loss from glaucoma can be reduced. Clinicians should make sure that patients continue taking their glaucoma drugs as prescribed and should keep an eye out for any negative side effects from any medical or surgical procedures used to treat glaucoma. Journal of current glaucoma practice 23 January 2023

Glaucoma Screening: Is AI the Answer?
Glaucoma, a largely asymptomatic and progressive disease, remains a global healthcare crisis: its prevalence is almost 3.4% between the ages of 40–80 years, with as many as 112 million individuals projected to be affected by glaucoma by 2040. As of date, it is estimated that more than nine out 10 of cases of glaucoma remain undiagnosed, with as many as 12 million people blind due to glaucoma. Glaucoma blindness can be minimized by the timely recognition of a patient's risk of disease and ensuring that high-risk patients remain within the ambit of specialist care. However, glaucoma screening is labor and time intensive, with the accuracy of diagnosis depending not only on the skill of the ophthalmologist but also on the availability and interpretation of long-term follow-up results. Journal of current glaucoma practice 1 May 2022

Evaluation of a nurse-led glaucoma assessment clinic for non-complex patients
The introduction of the nurse-led glaucoma assessment clinic service allowed patients to be reviewed safely, efficiently and satisfactorily. This new service subsequently allowed for more complex glaucoma patients to be seen by the ophthalmologists. Findings revealed that suitably trained glaucoma nurses are able to clinically assess and safely monitor stable non-complex glaucoma patients. Highlights the need for appropriate investment in clinical training and supervision to ensure that glaucoma assessment nurses are adequately prepared to undertake this new practice role. Journal of clinical nursing 3 March 2023

24-hour monitoring of intraocular pressure fluctuations using a contact lens sensor: diagnostic performance for Glaucoma progression
The 24-hour intraocular pressure (IOP) related fluctuations characteristics, as assessed by a contact lens sensor (CLS), may act as a risk factor for progression in open angle glaucoma (OAG). In association with other predictive factors of glaucoma progression, the CLS may help adjust treatment strategy earlier. Investigative ophthalmology & visual science 1 March 2023

_________________________________________________________________________________

Research

Association of blood pressure with rates of macular ganglion cell complex thinning in patients with glaucoma
In this cohort study, a combination of lower diastolic blood pressure and higher intraocular pressure at baseline was associated with faster rates of ganglion cell complex thinning. These findings support consideration of evaluating and addressing diastolic blood pressure as a therapeutic measure in patients with glaucoma if supported by appropriate clinical trials. JAMA 9 February 2023

Incidence of glaucoma-related adverse events in the first 5 years after pediatric lensectomy
In this cohort study, glaucoma-related adverse events were common after cataract surgery in children; age less than 3 months at surgery was associated with elevated risk of the adverse events in aphakic eyes. Children with pseudophakia, who were older at surgery, less frequently developed a glaucoma-related adverse event within 5 years of lensectomy. The findings suggest that ongoing monitoring for the development of glaucoma is needed after lensectomy at any age. JAMA Ophthalmology 16 December 2022

Causal association between Iritis or Uveitis and Glaucoma: A two-sample Mendelian randomisation study
Recent studies have suggested an association between iritis or uveitis and glaucoma. This study investigated the causal relationship between glaucoma and iritis and uveitis as exposures in a multi-ethnic population. Genes 3 March 2023

From bench to behavior: the role of lifestyle factors on intraocular pressure, neuroprotection, and disease progression in glaucoma
Current glaucoma management centers on intraocular pressure (IOP) reduction through pharmacological and surgical therapy. Despite broad interest in active management of glaucoma through lifestyle modifications, such recommendations have yet to be incorporated into standards of treatment. In this review, noteworthy preclinical studies and their translations in clinical populations are discussed to evaluate the roles of lifestyle factors in lowering IOP, offering neuroprotection, and/or slowing disease progression in those with open-angle glaucoma. Current literature suggests that aerobic exercise is associated with neuroprotection and decreased disease progression. Mindfulness is associated with IOP reductions and neuroprotection. Caffeine is associated with mild, transient IOP elevations of uncertain significance. Nicotinamide supplementation is associated with neuroprotection and short-term visual function improvement. This review also highlights knowledge gaps regarding these factors and opportunities to strengthen our understanding of their role in glaucoma, including future preclinical studies that elucidate underlying mechanisms and clinical studies with additional functional endpoints and longer follow-up. Clinical and experimental ophthalmology 1 March 2023

Diabetes mellitus and incident glaucoma in Australia: a 10-year cohort study from the 45 and Up Study
DM was associated with an increased risk of medical glaucoma only, there was no association identified with surgical glaucoma in the Australian population recruited in the 45 and Up Study. Annals of translational medicine 10 August 2022

Ocular and systemic factors associated with Glaucoma
Glaucoma is one of the leading causes of irreversible blindness in the world. Although numerous factors have been implicated in the pathogenesis of glaucoma, the main focus of management still remains lowering the intraocular pressure (IOP) by medical or surgical therapy. However, a major challenge is that many glaucoma patients continue to progress despite good control of IOP. In this regard, the importance of other coexisting factors that may contribute to disease progression needs to be explored. Ophthalmologists need to be aware of ocular risk factors and the impact of systemic diseases and their medications, along with lifestyle modifications on the course of glaucomatous optic neuropathy and adopt a holistic approach in treating the eye as well as the patient to alleviate the suffering from glaucoma in a comprehensive manner. Journal of current glaucoma practice 23 January 2023

_________________________________________________________________________________

Treatment

Current practice of trabeculectomy in a cohort of experienced glaucoma surgeons in Australia and New Zealand
Although a wide range of techniques for trabeculectomy exists among surgeons, there are consistent procedures currently in use to optimize patient outcomes. This report will assist surgeons in choosing which surgical techniques fit their best practice. Eye 3 May 2022

Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS)
Primary trabeculectomy had similar quality of life and safety outcomes and achieved a lower intraocular pressure compared with primary medication. BMJ 12 May 2021

Survival of visual function in patients with advanced glaucoma after standard guarded Trabeculectomy with MMC
Surgical intervention in patients with severe glaucoma remains controversial, especially in unilateral cases with a minimally affected fellow eye. Many question the benefit of trabeculectomy in such cases due to high complication rates and prolonged recovery. In this retrospective, non-comparative, interventional case series the authors aimed to determine the effect of trabeculectomy or combined phaco-trabeculectomy on the visual function of advanced glaucoma patients. Journal of clinical medicine 18 February 2023

The outcomes of a low-cost, non-valved glaucoma drainage device using mitomycin-C: 1-year results
Aurolab Aqueous Drainage Implant (AADI) with using mitomycin-C and ripcord during the surgery is an effective and relatively safe method of control of IOP in refractory and advanced cases of glaucoma, with an overall success rate of 94%. Graefe's archive for clinical and experimental ophthalmology 4 March 2023

Gonioscopy-assisted transluminal trabeculotomy for open-angle glaucoma with failed incisional glaucoma surgery: two-year results
GATT was safe and effective in treating refractory OAG patients who failed prior incisional glaucoma surgery. BMC ophthalmology 6 March 2023

_________________________________________________________________________________

Journals

This is just a sample of the journals the library subscribes to – you will need your library login

_________________________________________________________________________________

E-books

This is just a sample of the e-books the library subscribes to – you will need your library login

_________________________________________________________________________________

 

 

Previous Awareness Weeks

Missed out on a previous awareness week? You can now see previous awareness weeks here.